Skip to main content
Adam Schoenfeld, MD, Oncology, New York, NY, Memorial Sloan-Kettering Cancer Center


Oncology New York, NY

Thoracic Cancer

Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center

Overview of Dr. Schoenfeld

Dr. Adam Schoenfeld, MD is an oncologist in New York, New York. He is currently licensed to practice medicine in New York, New Jersey, and California. He is affiliated with Memorial Sloan-Kettering Cancer Center.

Education & Training

  • San Francisco General Hospital Medical CenterResidency, Internal Medicine, 2014 - 2017
  • UCSF
    UCSFClass of 2014, AOA

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2020 - 2023
  • NY State Medical License
    NY State Medical License 2017 - 2022
  • CA State Medical License
    CA State Medical License 2016 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Kaiser Permanente Medical Student Scholarship Award Kaiser Permanente, 2013
  • New England Journal of Medicine Scholar New England Journal of Medicine, 2012
  • Phi Beta Kappa Society Member Dartmouth College, 2009

Publications & Presentations


Journal Articles

  • Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients with Metastatic EGFR-Mutant Lung Cancers  
    Helena A Yu, Adam J Schoenfeld, Jamie E Chaft, Gregory J Riely, JAMA Oncology
  • Synthesis, Structure, Dynamics, and Selective Methylation of Platinum and Palladium Diphosphametallacyclobutane Complexes  
    Chapp TW, Schoenfeld A, Sanderson MD, Chang C, Glueck DS, Golen J, Moore C, Rheingold A, Organometallics, 2012
  • Effects of Linker Length on the Rate and Selectivity of Platinum-Catalyzed Asymmetric Alkylation of the Bis(isitylphosphino)alkanes IsHP(CH2)nPHIs (is = 2,4,6-(i-pr)3C...  
    Chapp TW, Schoenfeld A, Glueck DS, Organometallics, 2010


  • The CNS Germinoma Experience at UCSF from 1980 to 2010
    Schoenfeld A, Molinaro A, Banerjee A, Haas-Kogan D, Mueller S, 3rd International CNS Germ Cell Tumour Symposium, Cambridge, England, 2013


  • Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Study Finds Growing Reason to Be Wary of Some Reflux Drugs
    Study Finds Growing Reason to Be Wary of Some Reflux DrugsJanuary 29th, 2016
  • Popular Acid Reflux Drugs Are Linked to Kidney Disease Risk
    Popular Acid Reflux Drugs Are Linked to Kidney Disease RiskJanuary 11th, 2016

Professional Memberships

Hospital Affiliations